https://www.selleckchem.com/pr....oducts/salvianolic-a
Patients in the ERAS group had significantly better clinical and laboratory recovery parameters except for postoperative nausea and vomiting. Asignificantly lower incidence of paralytic ileus (20.9% vs. 3%) and ashorter length of postoperative stay (13 days vs. 9 days) was found in the ERAS group. The rehospitalization rate and 30-day morbidity were not different between the ERAS and control group. Implementation of the ERAS protocol in combination with mini-invasive approaches leads to better short-term postoperative outcome
Like
Comment
Share
